Medical Equipment & Cell Culture Lab Upgrades for Patients with Complex Diseases

Advancements in medical science regarding Stem Cells and Cell Therapy are opening new horizons in treating severe, complex diseases, including conditions with limited treatment options. However, harvesting and processing cells for therapeutic use cannot be carried out in conventional laboratories. Cells intended for patient administration require rigorous production and quality control processes inside high-purity, high-safety cell culture rooms (cleanrooms) equipped with specialized instruments, managed by expert personnel, and governed by standardized quality control systems.

To address this, the Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, established the Center of Excellence in Stem Cell and Cell Therapy. The center aims to develop knowledge and advance domestic cell production capabilities for clinical treatment in Thailand. To date, the laboratory has successfully manufactured cell products for clinical applications—such as corneal stem cell sheets and oral mucosal epithelial sheets for corneal disease patients—helping a number of patients regain their vision and quality of life.

Today, cell therapy is evolving rapidly, particularly in gene-edited cell therapies and novel cellular modalities, which hold strong potential for treating life-threatening and genetic conditions. Concurrently, the number of patients requiring treatment and the types of cell products needed are on the rise. However, limitations in existing equipment and laboratory space prevent the facility from meeting total patient demand. Acquiring specialized equipment and expanding cleanroom capacity are vital steps to enable medical teams to accommodate more patients and support innovative therapies.

Every stage of processing cells for patient re-infusion—from culturing and environmental control to quality and safety testing—requires meticulous oversight. This project focuses on procuring advanced equipment for cell culture and processing, renovating and expanding cleanroom facilities, and raising quality control systems to meet relevant Good Manufacturing Practice (GMP) standards, ensuring safe and efficient cell production for clinical use. Achieving self-sufficiency in medical cell production within Thailand will enhance local capacity to develop tailored treatments for Thai patients, reduce dependency on imported technologies or products, and lower import-related costs—ultimately broadening patient access to advanced therapies in the long run.

Your donations will go directly toward procuring cell culture and manufacturing equipment, renovating and expanding cleanroom spaces, upgrading laboratory facilities and quality control systems to meet international standards, and training specialized personnel, with an overall fundraising target of 24 million THB. Every contribution—from individual donors and major philanthropists to corporate supporters—is more than a donation for medical equipment. It is an investment in creating a "Space of Opportunity" that bridges the gap between laboratory research and clinical treatment, giving patients with hard-to-treat diseases greater access to therapeutic choices and fostering advanced medical technology development right here in Thailand.

Advancements in medical science regarding Stem Cells and Cell Therapy are opening new horizons in treating severe, complex diseases, including conditions with limited treatment options. However, harvesting and processing cells for therapeutic use cannot be carried out in conventional laboratories. Cells intended for patient administration require rigorous production and quality control processes inside high-purity, high-safety cell culture rooms (cleanrooms) equipped with specialized instruments, managed by expert personnel, and governed by standardized quality control systems.

To address this, the Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, established the Center of Excellence in Stem Cell and Cell Therapy. The center aims to develop knowledge and advance domestic cell production capabilities for clinical treatment in Thailand. To date, the laboratory has successfully manufactured cell products for clinical applications—such as corneal stem cell sheets and oral mucosal epithelial sheets for corneal disease patients—helping a number of patients regain their vision and quality of life.

Today, cell therapy is evolving rapidly, particularly in gene-edited cell therapies and novel cellular modalities, which hold strong potential for treating life-threatening and genetic conditions. Concurrently, the number of patients requiring treatment and the types of cell products needed are on the rise. However, limitations in existing equipment and laboratory space prevent the facility from meeting total patient demand. Acquiring specialized equipment and expanding cleanroom capacity are vital steps to enable medical teams to accommodate more patients and support innovative therapies.

Every stage of processing cells for patient re-infusion—from culturing and environmental control to quality and safety testing—requires meticulous oversight. This project focuses on procuring advanced equipment for cell culture and processing, renovating and expanding cleanroom facilities, and raising quality control systems to meet relevant Good Manufacturing Practice (GMP) standards, ensuring safe and efficient cell production for clinical use. Achieving self-sufficiency in medical cell production within Thailand will enhance local capacity to develop tailored treatments for Thai patients, reduce dependency on imported technologies or products, and lower import-related costs—ultimately broadening patient access to advanced therapies in the long run.

Your donations will go directly toward procuring cell culture and manufacturing equipment, renovating and expanding cleanroom spaces, upgrading laboratory facilities and quality control systems to meet international standards, and training specialized personnel, with an overall fundraising target of 24 million THB. Every contribution—from individual donors and major philanthropists to corporate supporters—is more than a donation for medical equipment. It is an investment in creating a "Space of Opportunity" that bridges the gap between laboratory research and clinical treatment, giving patients with hard-to-treat diseases greater access to therapeutic choices and fostering advanced medical technology development right here in Thailand.